GO Term | Evidence Code | PMID |
---|---|---|
antigen processing and presentation of exogenous peptide antigen via MHC class II | ||
positive regulation of immune response | ||
T cell receptor signaling pathway | ||
peptide antigen assembly with MHC class II protein complex | ||
adaptive immune response |
GO Term | Evidence Code | PMID |
---|---|---|
membrane | ||
transport vesicle membrane | ||
MHC class II protein complex | ||
endocytic vesicle membrane | ||
plasma membrane |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
MHC class II protein complex binding | ||
MHC class II receptor activity | ||
peptide antigen binding |
Gene Ontology |
---|
immune response |
InterPro |
---|
Immunoglobulin C1-set |
Immunoglobulin-like domain superfamily |
Immunoglobulin-like domain |
Immunoglobulin-like fold |
DO ID | Disease Name | Source |
---|---|---|
DOID:0040091 | autoimmune pancreatitis | |
DOID:0050012 | chikungunya | |
DOID:0050168 | autoimmune polyendocrine syndrome type 2 | |
DOID:0050185 | erythema multiforme | |
DOID:0050426 | Stevens-Johnson syndrome | |
DOID:0050748 | marginal zone lymphoma | |
DOID:0050784 | primary progressive multiple sclerosis | |
DOID:0050827 | rheumatic heart disease | |
DOID:0050840 | cervical dystonia | |
DOID:0060025 | immunoglobulin alpha deficiency |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
14961 | MGI:103070 | MOUSE20153 | ||
24738 | RGD:3467 | |||
24976 | RGD:3469 | |||
30762 | ZFIN:ZDB-GENE-980526-200 | DANRE42489 | ||
326022 | ZFIN:ZDB-GENE-030131-4747 | |||
368615 | ZFIN:ZDB-GENE-030616-319 | DANRE43735 | ||
368703 | ZFIN:ZDB-GENE-030616-99 | DANRE42448 | ||
368846 | ZFIN:ZDB-GENE-030616-396 | |||
368877 | DANRE42489 | |||
563286 | ZFIN:ZDB-GENE-030616-171 | DANRE43841 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024